Kushly Industries LLC
Agreed to an FTC order and paid consumer redress over allegedly unsupported claims that its CBD treats serious illness
This entry is about the United States — not the country you picked in the header.
According to Federal Trade Commission, May 17, 2021 · Read the source · +2 more
Resolved or closed
The source lists this matter as resolved or closed. The entry stays public so the record remains available.
Summary
Kushly Industries LLC of Scottsdale, Arizona, was the subject of what the FTC described in May 2021 as its seventh case challenging CBD health claims. The FTC alleged that the company and its chief executive marketed CBD gummies, softgel capsules and topical products online with false or unsubstantiated claims that they could treat conditions ranging from acne and psoriasis to cancer and multiple sclerosis, and that science proved benefits for hypertension, Parkinson's disease and Alzheimer's disease. On July 6, 2021, the FTC approved a final administrative consent order that prohibits such claims without adequate evidence and required a payment of $30,583.14, an amount the agency tied to what consumers had paid for the products. In August 2022, the FTC said it was sending almost $21,000 in refunds to 576 consumers who had bought Kushly's deceptively marketed CBD products.
What the source found
- The FTC alleged false or unsubstantiated claims that the products treat conditions including acne, psoriasis, cancer and multiple sclerosis.
- The FTC also alleged false claims that studies proved benefits for hypertension, Parkinson's disease and Alzheimer's disease.
- The final order required a $30,583.14 payment and bars unsupported health claims.
- In August 2022 the FTC returned almost $21,000 to 576 consumers, about $36 each.
Products named
- CBD gummies
- CBD softgel capsules
- CBD topicals
Timeline
FTC announces complaint and proposed consent order
FTC approves final administrative consent order
FTC announces refunds of almost $21,000 to 576 consumers
Sources
- Regulator
Federal Trade Commission · May 17, 2021
FTC Announces Latest Enforcement Action Halting Deceptive CBD Product Marketing - Regulator
Federal Trade Commission · Jul 6, 2021
Kushly Industries LLC, In the Matter of - Regulator
Federal Trade Commission · Aug 24, 2022
Federal Trade Commission Returning Almost $21,000 to Consumers Nationwide Who Bought Deceptively Marketed CBD Products from Kushly Industries
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
Settled in 2021 and refunds distributed in 2022. Current trading status of the business was not verified.
Comments
No comments yet.
Related entries
The full Red ListTell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.